United States : U.S. FDA Approves INVOKANA (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease

Press/Media: Press / Media

PeriodNov 5 2018

Media coverage

1

Media coverage

  • TitleUnited States : U.S. FDA Approves INVOKANA (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
    Media name/outletTendersInfo – News
    CountryIndia
    Date11/5/18
    PersonsRalph A Defronzo